Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Anemia, Sickle Cell
Interventions
PROCEDURE

Monthly blood transfusion regimen

Participants will receive blood transfusions at 3- to 4-week intervals for 6 months for the treatment of SCD-related anemia; the total number of transfusions that participants will receive will vary between six and eight.

BEHAVIORAL

Usual care

Participants will receive usual care for the treatment of SCD.

Trial Locations (14)

20001

Howard University, Washington D.C.

27514

University of North Carolina at Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

30912

Medical College of Georgia, Augusta

33021

Memorial Cancer Institute, Hollywood

33136

University of Miami Miller School of Medicine, Miami

45267

University of Cincinnati Medical Center, Cincinnati

48201

Karmanos Cancer Institute at Wayne State University, Detroit

63110

Washington University, St Louis

77555

University of Texas Medical Branch, Galveston

94117

Johns Hopkins, Baltimore

94609

Children's Hospital & Research Center at Oakland, Oakland

02118

Boston Medical Center, Boston

45229-3039

Cincinnati Children's Hospital, Cincinnati

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

UCSF Benioff Children's Hospital Oakland

OTHER

NCT00850018 - Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study | Biotech Hunter | Biotech Hunter